Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in

Status Not yet recruiting

Clinical Trial Summary

Bupivacaine is the most widely used local anesthetic agent across majority of the Cardiac Implantable Electronic device (CIED) implant procedures in the United States. It is hypothesized that the combination of Bupivacaine-Ketorolac-Ketamine (BKK) is more effective in alleviating perioperative and postoperative pain as compared to the use of bupivacaine alone. A few studies have been done to look for the effectiveness of BKK in abdominal surgical procedures. However, no study has been done to evaluate its efficacy and effectiveness in patients undergoing CIED insertion.

Clinical Trial Description

Bupivacaine is a widely used local anesthetic and is often administered by spinal injection prior to major surgical procedures. Ketorolac is a potent NSAID which is used for the short-term relief of moderate to severe pain. It's used for long term duration is generally limited due to its potential to cause GI ulcers/perforation and renal failure. A single dose of perioperative Ketorolac has been found to be effective in reducing opioid consumption. Ketamine is NMDA receptor antagonist and is used for its anesthetic, analgesic, and psychotomimetic effects. It is primarily used for induction and maintenance of anesthesia and induces a trance like state providing pain relief, sedation, and amnesia. Although an effective local anesthetic agent, bupivacaine has weak analgesic effect and is used in combination with several analgesic agents for effective perioperative and postoperative analgesia. A common drug used in this analgesic regimen usually includes opioids such as morphine, oxycodone, and fentanyl. Over the last few decades the United States has witnessed an opioid epidemic and post-surgical opioid prescription is one of the major contributors of this epidemic. An opioid free combination of Bupivacaine-Ketorolac-Ketamine (BKK) is thought to be effective in alleviating perioperative and postoperative pain. ;

Study Design

Related Conditions & MeSH terms

Pain Management

Clinical Trial Details

NCT number	NCT05575999
Study type	Interventional
Source	Kansas City Heart Rhythm Research Foundation
Contact	Donita Atkins
Phone	816-651-1969
Email	datkins@kchrf.com
Status	Not yet recruiting
Phase	Phase 1
Start date	April 2023
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03334929` - Virtual Reality Distraction for Anxiety Reduction During Trigger Points Procedures in Pain Medicine Clinic	N/A
Recruiting	`NCT06129383` - The Effect of Adding PIFP Block to SAP Block on Postoparative Pain Management in Patient Planned for Breast Surgery	N/A
Completed	`NCT06054945` - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Active, not recruiting	`NCT02276495` - Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?	N/A
Recruiting	`NCT04094246` - Battlefield Acupuncture Following Shoulder Surgery	N/A
Completed	`NCT05514236` - Effect of Virtual Reality and Music Therapy on Pain Relief in Outpatient Hysteroscopy	N/A
Recruiting	`NCT04809935` - EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy	Phase 4
Not yet recruiting	`NCT05492903` - COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)	N/A
Not yet recruiting	`NCT04328805` - Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.	Phase 4
Completed	`NCT02922101` - Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care	N/A
Completed	`NCT01541293` - Intrauterine Lidocaine for Laminaria	Phase 1
Not yet recruiting	`NCT01059487` - Bringing Acute and Wellness Care to Underserved Populations Using Traditional Chinese Medicine	Phase 0
Completed	`NCT03290378` - Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy	Phase 3
Recruiting	`NCT05794828` - Erector Spinae Regional Anesthesia for Pain Control	Early Phase 1
Active, not recruiting	`NCT04109885` - Paracervical Injection for Headache in the Emergency Department	Phase 2
Recruiting	`NCT05857202` - Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
Recruiting	`NCT03851042` - Virtual Reality for Postoperative Pain After Laparoscopic Hysterectomy	N/A
Completed	`NCT04566536` - NoL Monitor Performances of Nociceptive and Non-nociceptive Stimuli Discrimination During Robotic Surgery
Completed	`NCT03471390` - Improving Pain Management in Nursing Homes: a Pilot Study	N/A
Enrolling by invitation	`NCT02995278` - Usage and Plan of Care Changes Due to Drug Screenings

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms